These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 21682059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments.
    Food and Drug Administration, HHS.
    Fed Regist; 2012 May 11; 77(92):27591-3. PubMed ID: 22606729
    [Abstract] [Full Text] [Related]

  • 3. Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 May 21; 64(98):27666-93. PubMed ID: 10558542
    [Abstract] [Full Text] [Related]

  • 4. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Jun 04; 68(107):33362-81. PubMed ID: 12785379
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 May 09; 67(90):31123-5. PubMed ID: 12001971
    [Abstract] [Full Text] [Related]

  • 9. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
    Fed Regist; 1999 Aug 17; 64(158):44653-8. PubMed ID: 10558603
    [Abstract] [Full Text] [Related]

  • 10. Over-the-counter drug products containing analgesic/antipyretic active ingredients for internal use; required alcohol warning; final rule; compliance date. Food and Drug Administration, HHS.
    Fed Regist; 1999 Mar 17; 64(51):13066-7. PubMed ID: 10557605
    [Abstract] [Full Text] [Related]

  • 11. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan 03; 65(1):7-9. PubMed ID: 11010625
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug labeling; orally ingested over-the-counter drug products containing calcium, magnesium, and potassium. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Mar 24; 69(57):13725-35. PubMed ID: 15040351
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 May 09; 67(90):31125-7. PubMed ID: 12001972
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Apr 17; 68(74):18869-82. PubMed ID: 12701600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.